Holmusk is Solving Some of the Hardest Problems Facing This Generation, and We Pride Ourselves on the Diversity and Multidisciplinary Expertise of Our Team: Nawal Roy, CEO

Holmusk is a data analytics and health technology company on a mission to harness real-world evidence to transform both research and care for behavioral health. The company is driven by the belief that data can play a critical role in improving the quality of care and advancing research in this often-overlooked sector. Holmusk combines the power of AI with a leading behavioral health database to tackle the pressing challenges faced by both healthcare providers and researchers in the field of behavioral health. The goal is to make behavioral health care more effective, personalized, and accessible through the use of real-time data and advanced analytics.

One of Holmusk’s core offerings is HolCare EHR+, a platform designed to cater to the unique needs of behavioral health professionals. Unlike traditional electronic health records systems, HolCare EHR+ integrates measurement-based care directly into the platform. This means that clinicians can continually refine treatment plans based on data collected from patients, ensuring that care evolves with the patient’s needs. The platform is designed to be intuitive, helping clinicians stay focused on the patient while ensuring that data is leveraged to drive better outcomes. HolCare EHR+ simplifies the often-complicated workflows in behavioral health settings, giving healthcare providers the tools they need to offer more personalized, data-backed care.

Alongside HolCare EHR+, Holmusk also offers NeuroBlu Research, a powerful data analytics solution for researchers. This tool allows users to analyze vast amounts of patient data, enabling them to build cohorts, explore different datasets, and uncover valuable insights. NeuroBlu Research isn’t just for large research organizations—it’s designed to be accessible to anyone who wants to dive deeper into behavioral health data, whether they’re looking to understand patterns, test hypotheses, or discover new trends in treatment effectiveness. By making complex data easier to explore and understand, NeuroBlu Research provides researchers with the tools they need to push the boundaries of what we know about behavioral health.

Founded in 2015, Holmusk quickly established itself as a leader in the behavioral health space. With its headquarters in both Singapore and New York, the company’s global footprint allows it to address the unique challenges of different healthcare systems while still maintaining a unified vision of transforming behavioral health through data. Holmusk’s global perspective has fueled its drive to build solutions that can be applied anywhere, from clinical settings to research labs. In 2019, Holmusk was recognized as a Technology Pioneer by the World Economic Forum, a recognition that speaks to the impact Holmusk has already made in the field and the trust the global community places in its innovative approach.

Holmusk’s impact isn’t just about offering new products—it’s about rethinking how data can be used to improve patient care and drive forward research. For healthcare providers, HolCare EHR+ offers a more accurate way to track patient progress and adjust care based on real-time evidence. Gone are the days when treatment decisions were based solely on clinical intuition or outdated information. Instead, HolCare EHR+ empowers clinicians to make decisions based on up-to-date data that reflects the patient’s actual progress and needs.

For researchers, NeuroBlu Research opens up new possibilities. With access to vast datasets, researchers can explore patterns they might never have noticed before. NeuroBlu Research helps to identify trends in patient responses to treatment, uncover potential new therapies, and bring greater precision to behavioral health research. The ability to analyze and visualize complex data enables a deeper understanding of mental health conditions, ultimately paving the way for more effective treatments.

The combination of real-world evidence and AI technology lies at the core of Holmusk’s mission. By using advanced machine learning algorithms to sift through massive amounts of data, Holmusk’s platforms can identify correlations and trends that would be impossible for humans to detect manually. This approach reduces the margin of error in research and clinical decision-making, ensuring that healthcare providers and researchers can make decisions based on the most accurate and relevant information available. The use of AI is particularly beneficial in a field like behavioral health, where patterns can be subtle and complex. Holmusk’s platforms make it easier to spot those patterns and act on them.

Holmusk isn’t just creating technology for the sake of technology. Every solution the company develops is aimed at solving real problems in behavioral health. Behavioral health faces a number of challenges, from inconsistent care and a lack of reliable data to the difficulty of coordinating research across different institutions. Holmusk’s platforms address these challenges head-on by providing real-time, actionable insights that improve both the practice of medicine and the conduct of research. For example, HolCare EHR+ enables clinicians to continuously assess and adjust treatment plans based on the most current data, while NeuroBlu Research helps researchers to efficiently gather and analyze data from a variety of sources.

Holmusk is also deeply committed to accessibility. It is not enough for the company’s solutions to be powerful—they also need to be easy to use. The company’s platforms are designed to be adaptable to different workflows and organizations, recognizing that each institution or research team has its own unique needs and constraints. Holmusk’s solutions are flexible and scalable, ensuring that they can be implemented in a wide variety of settings, whether in a small practice or a large academic research institution. Holmusk understands that the success of its technology depends on how well it integrates into the daily routines of its users. Therefore, usability is a top priority in every product Holmusk develops.

The ultimate goal for Holmusk is to bridge the gap between research and practice. By making real-world data accessible and actionable, the company is helping to create a feedback loop in which new discoveries are quickly translated into practical applications in patient care. This synergy between research and clinical practice is critical for making progress in behavioral health, where the pace of innovation often lags behind the needs of patients. Holmusk’s platforms enable faster translation of research into real-world solutions, ensuring that new treatments and findings can be used to improve patient outcomes more quickly.

As Holmusk continues to grow and refine its technology, the company is positioned to play a key role in the future of behavioral health. Behavioral health care is on the verge of a transformation, and data is at the heart of this shift. By integrating real-time data into decision-making processes and making research findings more accessible, Holmusk is helping to shape the future of care for those with mental health conditions. The company’s use of AI to analyze vast datasets will undoubtedly become even more integral as healthcare systems move towards more data-driven models of care.

Holmusk’s influence goes beyond the individual providers and researchers who use its products. The company’s work is contributing to a larger movement in healthcare to make mental health treatment more personalized, efficient, and accessible. By focusing on real-world evidence and using AI to extract valuable insights, Holmusk is helping to accelerate progress in a field that is too often neglected. The company’s solutions are making it possible to better understand mental health conditions, improve treatment efficacy, and ensure that every patient receives the care they need to thrive.

The future of behavioral health is one in which data and technology are used to personalize care and drive meaningful improvements in treatment outcomes. Holmusk is at the forefront of this transformation, offering the tools and insights needed to make informed decisions about patient care and research. The company’s innovative approach to behavioral health is helping to ensure that everyone has access to better, more effective care, and that progress in the field continues at a rapid pace. Through its commitment to harnessing real-world evidence and advancing AI-powered solutions, Holmusk is creating a more connected, data-driven future for behavioral health care.

Nawal Roy, Founder & CEO, Holmusk

“We are advancing the frontier of behavioral health evidence, taking our suite of proprietary next-generation disease models and digital tools to improve lives on a global scale.”